Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass

Journal of Bone and Mineral Research

Volumn 13, Issue 7, 1998, Pages 1191-1202

  Sowers, M ^a   Randolph J F , Jr ^a   Crutchfield, M ^a   Jannausch, M L ^a   Shapiro, B ^a   Zhang, B ^a   La Pietra, M ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE GLUCURONIDE; FOLLITROPIN; GONADOTROPIN; PREGNANEDIOL; TESTOSTERONE;

ARTICLE; BONE DENSITY; BONE MASS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE URINE LEVEL; HUMAN; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; PREMENOPAUSE; RADIOIMMUNOASSAY;

EID: 0031836458     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.7.1191     Document Type: Article

References (30)

1. 1 Ohta H, Masuzawa T, Ikeda T, Suda Y, Makita K, Nozawa S 1992 Which is more osteoporosis‐inducing, menopause or oophorectomy? Bone Miner 19: 273–285.
2. 2 Lindsay R 1988 Sex steroid in the pathogenesis and prevention of osteoporosis. In: Riggs BL, Melton LJ (eds.) Osteoporosis: Etiology, Diagnosis, and Management. Raven Press, New York, NY, U.S.A., pp. 333–358.
3. 3 Drinkwater BL, Nilson K, Ott S, Chestnut CH III 1986 Bone mineral density after resumption of menses in amenorrheic athletes J Am Med Assoc 256: 380–382.
4. 4 Christiansen C, Christiansen MS, McNair P, Hagen C, Stocklund KE, Transbol I 1980 Prevention of early postmenopausal bone loss: Controlled 2‐year study in 315 normal females Eur J Clin Invest 10: 273–279.
5. 5 Lindsay R, Tohme JF 1990 Estrogen treatment of patient with established postmenopausal osteoporosis Obstet Gynecol 72: 290–295.
6. 6 Sowers MFR, Clark MK, Jannausch ML, Wallace RB 1993 Body size, estrogen use and thiazide diuretic use affects 5‐year radial bone loss in postmenopausal women Osteoporos Int 3: 314–321.
7. 7 Sowers MFR, Shapiro B, Gilbraith MA, Jannausch M 1990 Health and hormonal characteristics of women with low premenopausal bone mass Calcif Tissue Int 47: 130–135.
8. 8 Georgious E, Ntalies K, Papageorgiou Korkotsidis A, Proukakis C 1989 Bone mineral loss related to menstrual history Acta Orthop Scand 60: 192–194.
9. 9 Lloyd T, Myers C, Buchanan JR, Demers LM 1988 Collegiate women athletes with irregular menses during adolescence have decreased bone density Obstet Gynecol 72: 639–642.
10. 10 Marcus R, Cann C, Madvig P, Minkoff J, Goddard M, Bayer M, Martin M, Gaudiani L, Haskell W, Genant H 1985 Menstrual function and bone mass in elite women distance runners Ann Intern Med 102: 158–163.
11. 11 Prior JC, Vigna YM, Schecter MT, Burgess AE 1990 Spinal bone loss and ovulatory disturbances N Engl J Med 323: 1221–1227.
12. 12 Newton‐John HF, Morgan DB 1968 Osteoporosis: Disease senescence? Lancet 1: 323–333.
13. 13 Sowers MFR, Boehnke M, Jannausch ML, Crutchfield M, Corton G, Burns TL 1992 Familiality and partitioning of the variability of femoral bone mineral density in women of child‐bearing age Calcif Tissue Int 50: 110–114.
14. 14 Wellens R, Cameron C, Guo S, Roche AF, Reo NV, Siervogel RM 1994 Body composition in white adults by dual‐energy x‐ray absorptiometry, densitometry, and total body water Am J Clin Nutr 59: 547–555.
15. 15 Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger RS Jr 1985 Physical activity assessment methodology in the Five City Project Am J Epidemiol 121: 91–106.
16. 16 Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L 1986 A data‐based approach to diet questionnaire design and testing Am J Epidemiol 124: 453–469.
17. 17 Cekan SZ, Eksac MS, Wang S, Shi S, Masironi B, Langren BM, Diczfalusy E 1986 The prediction and/or detection of ovulation by means of urinary sterol assays Contraception 33: 327–345.
18. 18 Metcalf MG, Mackenzie JA 1984 Indices of ovulation: Comparison of plasma and salivary levels of progesterone with urinary pregnanediol J Endocrinol 100: 75–80.
19. 19 Carter DR, Bouxsein ML, Marcus R 1992 New approaches for interpreting projected bone densitometry data J Bone Miner Res 7: 137–145.
20. 20 Farin G 1988 Curves and Surfaces for Computer‐Aided Geometric Modeling, Academic Press, New York, NY, U.S.A.
21. 21 Waller K, Reim J, Fenster L, Swan SH, Brumback B, Windham GC, Lasley B, Ettinger B, Marcus R 1996 Bone mass and subtle abnormalities in ovulatory function in healthy women J Clin Endocrinol Metab 81: 663–668.
22. 22 Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R 1990 Decreased bone density in adolescent girls with anorexia nervosa Pediatrics 86: 440–447.
23. 23 Barr SI, Prior JC, Vigna YM 1994 Restrained eating and ovulatory disturbances: Possible implications for bone health Am J Clin Nutr 59: 92–97.
24. 24 Myburgh KH, Bachrach LK, Lewis B, Kent K, Marcus R 1993 Low bone mineral density at axial and appendicular sites in amenorrheic athletes Med Sci Sports Exerc 25: 1197–1202.
25. 25 Hetland ML, Haarbo J, Christianson C 1993 Running induces menstrual disturbances but bone loss is unaffected, except in amenorrheic women Am J Med 95: 53–60.
26. 26 Sowers MFR, LaPietra MT 1995 Menopause: Its epidemiology and potential association with chronic diseases Epidemiol Rev 17: 287–302.
27. 27 Tremollieres FA, Strong DD, Baylink DJ, Mohan S 1992 Progesterone and promegesterone stimulate human bone cell proliferation and insulin‐like growth factor‐2 production Acta Endocrinol 126: 329–337.
28. 28 Prior JC 1990 Progesterone as a bone‐trophic hormone Endocrinol Rev 11: 386–398.
29. 29 Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC 1994 Cyclic Medroxyprogesterone treatment increase bone density: A controlled trial in active women with menstrual cycle disturbances Am J Med 96: 521–530.
30. 30 De Souza MJ, Miller BE, Sequenzia LC, Luciano AA, Ulreich S, Stier S, Prestwood K, Lasley BL 1997 Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners J Clin Endocrinol Metab 82: 2867–2876.